February 1, 2023
Immunophotonics Presenting at BIO CEO & Investor Conference February 6 – 9, 2023
Immunophotonics, Inc. is grateful to NCI (the National Cancer Institute of NIH) and its SBIR Investor Initiatives Team for sponsoring...
Read More
January 26, 2023
Immunophotonics Announces 1st Patient Dosed in IP-IIO-622 Phase 1b/2a Clinical Trial in Advanced Solid Tumor Indications
Immunophotonics, Inc. announced the initiation of recruitment and the dosing of its first patient in a clinical trial assessing safety...
Read More
January 16, 2023
SIO Annual Scientific Meeting, January 19 – 23, 2023
Tomas Hode, PhD, Co-Founder, CIO, and President at @Immunophotonics, Inc. will be attending the Society of Interventional Oncology (SIO) 2023...
Read More
January 11, 2023
Poster Presented at the ESMO Immuno-Oncology Congress
A poster summarizing the results of the Phase 1b portion of the study SAKK 66/17 concerning the combination of thermal...
Read More
December 28, 2022
JPM 2023 San Francisco, January 9 – 12, 2023
Our networking is well underway for the JPM 2023. Attending the annual summit Lu Alleruzzo at JPM Healthcare Conference, Theresa...
Read More
December 20, 2022
Immunophotonics, Inc. was recently named one of six awardees in Johnson & Johnson’s Innovations for Vets: Lung Cancer and Physical Trauma QuickFire Challenge.
We are grateful to Johnson & Johnson Innovation for funding this vital work and are honored to advance medicine for...
Read More
December 5, 2022
Florida Venture Summit
Immunophotonics, Inc is proud to have been selected by YoungStartup Ventures to present at the Florida Venture Summit in Miami...
Read More
November 8, 2022
Wei Chen’s Paper Publication in the Journal for ImmunoTherapy of Cancer (JITC)
Congratulations to Professor Wei Chen and his lab at the University of Oklahoma for their publication in one of the...
Read More
October 26, 2022
Immunophotonics Co-Founder Wei Chen, Ph.D. Awarded $2.5 Million Grant by the National Cancer Institute
Immunophotonics, Inc. would like to congratulate Wei Chen, Ph.D. on his recently awarded Grant by the National Cancer Institute of...
Read More
October 13, 2022
Bio-Europe 2022, October 24 – 26
Dr. Theresa Visarius, Immunophotonics Vice President of Business Development and Managing Director of Immunophotonics Switzerland will be attending Bio-Europe 2022...
Read More